EPA dioxin study called flawed
EPA`s dioxin reassessment took a drubbing from industry scientists last week at a meeting of EPA`s science advisory board (SAB), which is charged with reviewing the reassessment`s scientific underpinnings. {open_quotes}The scientific evidence available today does not support EPA`s conclusions that adverse human health effects can be expected at or near background exposure levels,{close_quotes} says Thomas B. Starr, principal an Environ Corp. and chairman of its dioxin expert panel. He says EPA uses {open_quotes}many unproved assumptions and untested hypotheses{close_quotes} to back up its claim. SAB agrees, and has directed EPA to revise its report. Environ`s dioxin panel is supported by the American Forest and Paper Association. William Carroll, scientist with CMA`s Chlorine Chemistry Council, says EPA`s linking laboratory animal effects to humans at background exposures {open_quotes}is not justified by the science that`s out there.{close_quotes} He is concerned that the public may interpret hypothetical risks as real.
- OSTI ID:
- 494174
- Journal Information:
- Chemical Week, Journal Name: Chemical Week Journal Issue: 20 Vol. 156; ISSN CHWKA9; ISSN 0009-272X
- Country of Publication:
- United States
- Language:
- English
Similar Records
Review of EPA calls for more research spending
A flagship risk assessment: EPA reassesses dioxin in an open forum